93 related articles for article (PubMed ID: 9371251)
1. Retinoic acid conjugates as potential antitumor agents: synthesis and biological activity of conjugates with Ara-A, Ara-C, 3(2H)-furanone, and aniline mustard moieties.
Manfredini S; Simoni D; Ferroni R; Bazzanini R; Vertuani S; Hatse S; Balzarini J; De Clercq E
J Med Chem; 1997 Nov; 40(23):3851-7. PubMed ID: 9371251
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
[TBL] [Abstract][Full Text] [Related]
3. All- trans-retinoic acid increases cytotoxicity of 1-beta-D-arabinofuranosylcytosine in NB4 cells.
Flanagan SA; Meckling KA
Cancer Chemother Pharmacol; 2003 May; 51(5):363-75. PubMed ID: 12736759
[TBL] [Abstract][Full Text] [Related]
4. PEG-Ara-C conjugates for controlled release.
Schiavon O; Pasut G; Moro S; Orsolini P; Guiotto A; Veronese FM
Eur J Med Chem; 2004 Feb; 39(2):123-33. PubMed ID: 14987821
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of higher homologues of retinoic acid.
Winum JY; Kamal M; Defacque H; Commes T; Chavis C; Lucas M; Marti J; Montero JL
Farmaco; 1997 Jan; 52(1):39-42. PubMed ID: 9181680
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-beta-arabinofuranosylcytosine.
Liu B; Cui C; Duan W; Zhao M; Peng S; Wang L; Liu H; Cui G
Eur J Med Chem; 2009 Sep; 44(9):3596-600. PubMed ID: 19321234
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of DAAS derivatives and their enhancement of HL-60 leukemia cell differentiation.
Kim SH; Chung SY; Kim YW; Kim TS; Choi BG
Arch Pharm Res; 2008 Mar; 31(3):300-4. PubMed ID: 18409041
[TBL] [Abstract][Full Text] [Related]
8. Translocator protein (TSPO) ligand-Ara-C (cytarabine) conjugates as a strategy to deliver antineoplastic drugs and to enhance drug clinical potential.
Denora N; Laquintana V; Trapani A; Lopedota A; Latrofa A; Gallo JM; Trapani G
Mol Pharm; 2010 Dec; 7(6):2255-69. PubMed ID: 20958082
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic arabinofuranosyl cytosine derivatives in liposomes.
Schwendener R; Schott H
Methods Enzymol; 2005; 391():58-70. PubMed ID: 15721374
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage.
Kapuriya N; Kapuriya K; Zhang X; Chou TC; Kakadiya R; Wu YT; Tsai TH; Chen YT; Lee TC; Shah A; Naliapara Y; Su TL
Bioorg Med Chem; 2008 May; 16(10):5413-23. PubMed ID: 18450456
[TBL] [Abstract][Full Text] [Related]
11. Preparation and biological evaluation of 5-substituted retinoic acids.
Wada A; Matsuura N; Mizuguchi Y; Nakagawa K; Ito M; Okano T
Bioorg Med Chem; 2008 Sep; 16(18):8471-81. PubMed ID: 18760926
[TBL] [Abstract][Full Text] [Related]
12. Influence of the level of gamma-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid.
Palomares T; Castro B; del Olmo M; Iglesias A; Bilbao P; Alonso-Varona A
Anticancer Drugs; 2006 Nov; 17(10):1127-39. PubMed ID: 17075312
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antiproliferative activity of two new heteroannelated (-)-muricatacin mimics.
Popsavin V; Srećo B; Benedeković G; Popsavin M; Francuz J; Kojić V; Bogdanović G
Bioorg Med Chem Lett; 2008 Oct; 18(19):5182-5. PubMed ID: 18790637
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.
Pérez-Sacau E; Díaz-Peñate RG; Estévez-Braun A; Ravelo AG; García-Castellano JM; Pardo L; Campillo M
J Med Chem; 2007 Feb; 50(4):696-706. PubMed ID: 17249647
[TBL] [Abstract][Full Text] [Related]
16. Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells.
Bertagnolo V; Neri LM; Marchisio M; Mischiati C; Capitani S
Cancer Res; 1999 Feb; 59(3):542-6. PubMed ID: 9973197
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, X-ray crystal structural study, antiviral and cytostatic evaluations of the novel unsaturated acyclic and epoxide nucleoside analogues.
Kristafor V; Raić-Malić S; Cetina M; Kralj M; Suman L; Pavelić K; Balzarini J; De Clercq E; Mintas M
Bioorg Med Chem; 2006 Dec; 14(23):8126-38. PubMed ID: 16889965
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxicity of novel fatty acid-nucleoside conjugates.
Zhang YX; Dai GF; Wang L; Tao JC
Bioorg Med Chem Lett; 2007 Mar; 17(6):1613-5. PubMed ID: 17239599
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and preliminary biological evaluation of beta-carotene and retinoic acid oxidation products.
Kithsiri Wijeratne EM; Liu MX; Kantipudi NB; Brochini CB; Leslie Gunatilaka AA; Canfield LM
Bioorg Med Chem; 2006 Dec; 14(23):7875-9. PubMed ID: 16908162
[TBL] [Abstract][Full Text] [Related]
20. [Studies on compounds of tumor prevention--synthesis of derivatives of retinoic acid].
Xu SP; Guo ZR; Yuan ZL; Li LM; Huang L
Yao Xue Xue Bao; 1981 Sep; 16(9):678-86. PubMed ID: 7331817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
